Table 2.
Sample | Antioxidant Activity | Anti-Ageing Activity | Anti-Hyperpigmentation Activity |
---|---|---|---|
ORAC | Elastase Inhibition | Tyrosinase Inhibition | |
(µmol TEAC/mg extract) | (IC50, mg extract/mL) | (IC50, mg extract/mL) | |
Cf1 | 0.64 ± 0.18 | 42.58 (37.38, 49.88) | >100 ** |
Cf2 | 0.54 ± 0.22 | 60.35 (50.71, 73.43) | 78.59 (61.41, 100.70) |
Cf3 | 0.59 ± 0.26 | 34.74 (24.57, 49.16) | >100 ** |
Cf4 | 1.29 ± 0.26 | 38.11 (30.42, 49.52) | 40.89 (30.26, 54.43) |
S1 | 1.94 ± 0.08 | 44.29 (39.10, 53.44) | 82.51 (57.12, 108.39) |
S2 | 1.19 ± 0.10 | >300 * | 3.70 (3.26, 4.42) |
S3 | 1.24 ± 0.06 | 17.96 (12.36, 25.83) | 10.40 (5.02, 18.15) |
* The maximum concentration tested was 300 mg/mL; ** The maximum concentration tested was 100 mg/mL.